Better care of immature infants; has it influenced long-term pulmonary outcome?

Thomas Halvorsen1, Britt Torunn Skadberg, Geir Egil Eide

  • 1Department of Clinical Medicine, University of Bergen, Norway. thomas.halvorsen@pedi.uib.no

Insights

Infants born extremely prematurely in the 1990s showed no lung function improvement compared to those born in the 1980s. Long-term airway obstruction remains a significant outcome for extremely preterm infants, regardless of birth era.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Perinatal Medicine

Background:

  • Extremely preterm infants (<28 weeks gestation or <1000g birthweight) face long-term respiratory challenges.
  • Lung function outcomes in extremely preterm survivors have been studied across different neonatal care eras.

Purpose of the Study:

  • To compare long-term lung function in extremely preterm infants born in the early 1980s versus the early 1990s.
  • To investigate the impact of neonatal factors on pulmonary outcomes in these cohorts.

Main Methods:

  • Population-based, controlled cohort study.
  • Lung function assessed in extremely preterm infants (born 1982-85 and 1991-92) and matched term-born controls.
  • Analysis included bronchopulmonary dysplasia incidence and lung function parameters like airway obstruction and hyper-responsiveness.

Main Results:

  • Similar rates of bronchopulmonary dysplasia in both preterm cohorts.
  • Both preterm groups exhibited increased airway obstruction, hyper-responsiveness, and hyperinflation compared to controls.
  • Neonatal respiratory disease, oxygen dependence, lack of antenatal corticosteroids, and prolonged oxygen treatment predicted similar long-term airway obstruction in both cohorts.

Conclusions:

  • Extremely preterm infants born in different neonatal care eras experience similar long-term lung function deficits.
  • Airway obstruction remains a prevalent long-term consequence for extremely preterm infants.
  • Extended oxygen supplementation is often necessary, highlighting ongoing challenges in managing these vulnerable infants.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...